Photo by atikahakhtar from unsplash
Nivolumab is one of the targeted cancer therapy agent that acts to increase the immune responses by inhibition of antiprogrammed‐death‐receptor 1, which is one of the check points of the… Click to show full abstract
Nivolumab is one of the targeted cancer therapy agent that acts to increase the immune responses by inhibition of antiprogrammed‐death‐receptor 1, which is one of the check points of the immune response. Nivolumab can be used to treat malign melanoma, lung, renal, head and neck, colorectal, hepatocellular cancers, and special cases of Hodgkin lymphoma.
Keywords:
plaque morphea;
induced plaque;
malign;
morphea malign;
nivolumab induced;
malign melanoma
Journal Title: Journal of Cosmetic Dermatology
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Cosmetic Dermatology
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!